|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4245 | |
| A61P 9/00 | |||
| A61K 45/06 | |||
| A61K 31/366 |
| (11) | Patento numeris | 2809321 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13702219.0 |
| Europos patento paraiškos padavimo data | 2013-01-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-12-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/051871 |
| Data | 2013-01-31 |
| (87) | Numeris | WO 2013/113799 |
| Data | 2013-08-08 |
| (30) | Numeris | Data | Šalis |
| 201261593638 P | 2012-02-01 | US |
| (72) |
BYLOCK, Lars Anders, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | PHENYL-C-OXADIAZOLE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE PRODUCTION FOR USE IN COMBINATION THERAPY |
| PHENYL-C-OXADIAZOLE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE PRODUCTION FOR USE IN COMBINATION THERAPY |